Valproate Sodium Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Valproate Sodium Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Dec 30, 2020.

Shortage details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9785-10
Dosage Form
Injection
Presentation
Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)
Initial Posting
Dec 30, 2020

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.